» Authors » Ronan M Conroy

Ronan M Conroy

Explore the profile of Ronan M Conroy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 73
Citations 1895
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Macdonald S, France N, Hodgson I, Ali F, Dewi C, Abdurrakhman I, et al.
BMC Glob Public Health . 2024 Dec; 2(1):31. PMID: 39681934
Background: Self-stigma among people who have tuberculosis (TB) can contribute to non-adherence to medication and disengagement from care. It can manifest in feelings of worthlessness, shame, and guilt, leading to...
2.
Phillip E, Walsh A, Jewitt S, Elnakoury F, Simon J, Conroy R, et al.
BMC Public Health . 2024 Aug; 24(1):2233. PMID: 39152390
Background: Despite the extensive use of community-based participatory research (CBPR) in health-related projects, there is limited work on how CBPR processes result in outcomes, especially in household and ambient air...
3.
Conroy R, Golden J, Malone C
BJPsych Bull . 2024 Aug; :1-4. PMID: 39113247
Since climate change affects psychiatric, neurological and neuropsychological disorders, as well as brain development, the Irish Doctors for the Environment working group on mental health has changed its title and...
4.
Conroy R, Fitzgerald K
BMC Med Educ . 2023 Nov; 23(1):829. PMID: 37924033
Background: The Covid-19 pandemic has resulted in many student populations learning online in lockdown. While the mental health consequences of lockdown are increasingly understood, the core features of 'cabin fever'...
5.
Wu Y, Levis B, Daray F, Ioannidis J, Patten S, Cuijpers P, et al.
Psychol Assess . 2023 Jan; 35(2):95-114. PMID: 36689386
The seven-item Hospital Anxiety and Depression Scale Depression subscale (HADS-D) and the total score of the 14-item HADS (HADS-T) are both used for major depression screening. Compared to the HADS-D,...
6.
Campbell A, Morris G, Sanfeliu A, Augusto J, Langa E, Kesavan J, et al.
Mol Ther Nucleic Acids . 2022 May; 28:514-529. PMID: 35592499
Angelman syndrome (AS) is a severe neurodevelopmental disorder featuring ataxia, cognitive impairment, and drug-resistant epilepsy. AS is caused by mutations or deletion of the maternal copy of the paternally imprinted...
7.
Alqahtani M, Abdulrahman A, Almadani A, Alali S, Al Zamrooni A, Hejab A, et al.
Sci Rep . 2021 May; 11(1):9927. PMID: 33976287
Convalescent plasma (CP) therapy in COVID-19 disease may improve clinical outcome in severe disease. This pilot study was undertaken to inform feasibility and safety of further definitive studies. This was...
8.
Reschke C, Silva L, Vangoor V, Rosso M, David B, Cavanagh B, et al.
Mol Ther . 2021 Feb; 29(6):2041-2052. PMID: 33609732
Oligonucleotide therapies offer precision treatments for a variety of neurological diseases, including epilepsy, but their deployment is hampered by the blood-brain barrier (BBB). Previous studies showed that intracerebroventricular injection of...
9.
Connolly W, Rafter N, Conroy R, Stuart C, Hickey A, Williams D
BMJ Qual Saf . 2021 Jan; 30(7):547-558. PMID: 33436402
Objectives: To quantify the prevalence and nature of adverse events in acute Irish hospitals in 2015 and to assess the impact of the National Clinical Programmes and the National Clinical...
10.
McKay M, Cannon M, Chambers D, Conroy R, Coughlan H, Dodd P, et al.
Acta Psychiatr Scand . 2020 Dec; 143(3):189-205. PMID: 33315268
Objective: To systematically review evidence for the association between trauma experienced in childhood or adolescence, and the subsequent experience of affective or psychotic mental disorders in adulthood. Methods: Electronic databases...